
Gemfibrozil
CAS No. 25812-30-0
Gemfibrozil ( CI-719 | Lopid )
产品货号. M13780 CAS No. 25812-30-0
Gemfibrozil 是一种 PPAR-α 激活剂,为一种降脂剂;Gemfibrozil 同时是 P450 的非选择性抑制剂,对 CYP2C9,2C19,2C8 和 1A2 的 Ki 值分别为 5.8,24,69 和 82 μM。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
25MG | ¥243 | 有现货 |
![]() ![]() |
50MG | ¥308 | 有现货 |
![]() ![]() |
100MG | ¥405 | 有现货 |
![]() ![]() |
200MG | ¥510 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Gemfibrozil
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Gemfibrozil 是一种 PPAR-α 激活剂,为一种降脂剂;Gemfibrozil 同时是 P450 的非选择性抑制剂,对 CYP2C9,2C19,2C8 和 1A2 的 Ki 值分别为 5.8,24,69 和 82 μM。
-
产品描述Gemfibrozil (Lopid) is an oral drug used to lower lipid levels. It belongs to a group of drugs known as fibrates. Increases activity of Peroxisome proliferator-activated receptor-alpha (PPARα) 'transcription factor ligand' , a receptor that is involved in metabolism of carbohydrates and fats, as well as adipose tissue differentiation. This increase in the synthesis of lipoprotein lipase thereby increases the clearance of triglycerides.
-
体外实验——
-
体内实验——
-
同义词CI-719 | Lopid
-
通路Metabolic Enzyme/Protease
-
靶点PPAR
-
受体PPARα
-
研究领域Metabolic Disease
-
适应症——
化学信息
-
CAS Number25812-30-0
-
分子量250.33
-
分子式C15H22O3
-
纯度>98% (HPLC)
-
溶解度Ethanol: 50 mg/mL (199.73 mM); DMSO: 50 mg/mL (199.73 mM)
-
SMILESCC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
-
化学全称5-(2,5-dimethylphenoxy)-2,2-dimethylpentanoic acid
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Clavey V, et al. Cell Physiol Biochem. 1999;9(3):139-49.